[ad_1] <br><a href="https://news.google.com/atom/articles/CBMipgFodHRwczovL3d3dy5tYXJrZXRzY3JlZW5lci5jb20vcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1sYXRlLWJyZWFraW5nLVBoYXNlLTMtQ09QRC1yZXN1bHRzLXByZXNlbnRlZC1hdC1BVFMtYW5kLXNpbXVsdGEtNDM5MDg5ODcv0gGqAWh0dHBzOi8vd3d3Lm1hcmtldHNjcmVlbmVyLmNvbS9hbXAvcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1sYXRlLWJyZWFraW5nLVBoYXNlLTMtQ09QRC1yZXN1bHRzLXByZXNlbnRlZC1hdC1BVFMtYW5kLXNpbXVsdGEtNDM5MDg5ODcv?oc=5" target="_blank" rel="noopener">Press Release : Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine</a> <font color="#6f6f6f">Marketscreener.com</font> <br>[ad_2] <br><a href="https://news.google.com/atom/articles/CBMipgFodHRwczovL3d3dy5tYXJrZXRzY3JlZW5lci5jb20vcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1sYXRlLWJyZWFraW5nLVBoYXNlLTMtQ09QRC1yZXN1bHRzLXByZXNlbnRlZC1hdC1BVFMtYW5kLXNpbXVsdGEtNDM5MDg5ODcv0gGqAWh0dHBzOi8vd3d3Lm1hcmtldHNjcmVlbmVyLmNvbS9hbXAvcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1sYXRlLWJyZWFraW5nLVBoYXNlLTMtQ09QRC1yZXN1bHRzLXByZXNlbnRlZC1hdC1BVFMtYW5kLXNpbXVsdGEtNDM5MDg5ODcv?oc=5">Source link </a>